Mobia Medical, Inc. (NASDAQ:MOBI) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Mobia Medical, Inc. (NASDAQ:MOBI) have received a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating on the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $20.75.

Several research analysts have recently commented on the company. Wolfe Research began coverage on Mobia Medical in a report on Tuesday, June 2nd. They set an “outperform” rating for the company. Zacks Research raised shares of Mobia Medical to a “hold” rating in a research note on Wednesday, June 3rd. Wall Street Zen upgraded shares of Mobia Medical from a “sell” rating to a “hold” rating in a research report on Sunday, June 14th. Weiss Ratings initiated coverage on shares of Mobia Medical in a report on Wednesday, August 12th. They issued a “sell (e-)” rating on the stock. Finally, JPMorgan Chase & Co. raised their price objective on shares of Mobia Medical from $15.00 to $17.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th.

Mobia Medical Price Performance

NASDAQ MOBI opened at $10.03 on Thursday. Mobia Medical has a 1 year low of $9.88 and a 1 year high of $15.29. The company has a quick ratio of 12.80, a current ratio of 13.28 and a debt-to-equity ratio of 0.04. The stock has a market cap of $333.90 million and a PE ratio of -0.50. The business has a 50 day moving average price of $11.51.

Mobia Medical (NASDAQ:MOBI) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($1.10) earnings per share for the quarter, missing the consensus estimate of ($0.83) by ($0.27). The firm had revenue of $13.51 million for the quarter. Mobia Medical’s quarterly revenue was up 102.4% compared to the same quarter last year. On average, research analysts anticipate that Mobia Medical will post -2.63 EPS for the current year.

Insider Buying and Selling

In other news, Director Casey Tansey purchased 35,572 shares of the company’s stock in a transaction on Thursday, August 13th. The stock was purchased at an average price of $11.51 per share, with a total value of $409,433.72. Following the completion of the purchase, the director directly owned 268,904 shares in the company, valued at approximately $3,095,085.04. This trade represents a 15.25% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders acquired a total of 85,000 shares of company stock valued at $995,767 over the last quarter.

Hedge Funds Weigh In On Mobia Medical

A hedge fund recently bought a new position in Mobia Medical stock. Citadel Advisors LLC bought a new position in Mobia Medical, Inc. (NASDAQ:MOBI) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 50,000 shares of the company’s stock, valued at approximately $670,000. Citadel Advisors LLC owned approximately 0.15% of Mobia Medical at the end of the most recent reporting period.

Mobia Medical Company Profile

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.